| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(02)01264-5 |
| P698 | PubMed publication ID | 11906706 |
| P2093 | author name string | Kaoru Kobayashi | |
| Ikuyo Tsukamoto | |||
| Chieko Terada | |||
| P2860 | cites work | JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain | Q24308838 |
| Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms | Q24312029 | ||
| Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2 | Q24313872 | ||
| The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 | ||
| Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development | Q28268881 | ||
| Apoptosis by death factor | Q28304002 | ||
| Retinoic acid repressed the expression of c-fos and c-jun and induced apoptosis in regenerating rat liver after partial hepatectomy | Q28564781 | ||
| AP-1 in cell proliferation and survival | Q29615217 | ||
| Cell cycle control and cancer | Q29617536 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| AP-1 function and regulation | Q29618422 | ||
| Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun | Q29620103 | ||
| Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain | Q29620169 | ||
| Activation of Jun kinase is an early event in hepatic regeneration | Q34202651 | ||
| AP-1 in mouse development and tumorigenesis | Q34279346 | ||
| Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration | Q34368036 | ||
| Phosphorylation of c-jun mediated by MAP kinases. | Q34947174 | ||
| Apoptosis induced by anticancer drugs | Q35233723 | ||
| Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells | Q36563976 | ||
| Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging | Q36761547 | ||
| Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain | Q37055760 | ||
| Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation | Q37141859 | ||
| Drug-target interactions: only the first step in the commitment to a programmed cell death? | Q37188769 | ||
| Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. | Q40300975 | ||
| Apoptosis. Its significance in cancer and cancer therapy | Q40739570 | ||
| Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. | Q41218044 | ||
| MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? | Q41345475 | ||
| Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia | Q41714603 | ||
| Genetic determinants of p53-induced apoptosis and growth arrest | Q42812233 | ||
| Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 | Q42825163 | ||
| Comparison of in vitro cell cytotoxic assays for tumor necrosis factor | Q44180676 | ||
| Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. | Q53541288 | ||
| c-Jun is essential for normal mouse development and hepatogenesis | Q57083732 | ||
| Tumor necrosis factor primes hepatocytes for DNA replication in the rat | Q58022178 | ||
| Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 | Q59054204 | ||
| Quercetin inhibited DNA synthesis and induced apoptosis associated with increase in c-fos mRNA level and the upregulation of p21WAF1CIP1 mRNA and protein expression during liver regeneration after partial hepatectomy | Q74615819 | ||
| Induction of apoptosis in neoplastic cells by depletion of vitamin B12 | Q82498461 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatectomy | Q1514021 |
| P304 | page(s) | 19-24 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Methotrexate-induced apoptosis in hepatocytes after partial hepatectomy | |
| P478 | volume | 438 |
| Q42952495 | Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma. |
| Q60300547 | Cytoprotective effects of molsidomine against methotrexate-induced hepatotoxicity: an experimental rat study |
| Q36669837 | Effect of methotrexate exposure at late gestation on development of telencephalon in rat fetal brain |
| Q37120987 | Effect of methotrexate exposure at middle gestation on the inner plate of the ocular cup and lens in the rat fetus |
| Q35924108 | Effect of methotrexate on cerebellar development in infant rats |
| Q33579518 | Effect of methotrexate on neuroepithelium in the rat fetal brain |
| Q39569990 | Hepatoprotective efficacy of ursodeoxycholic acid in pediatrics acute lymphoblastic leukemia |
| Q35976422 | Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy |
| Q54751155 | Methotrexate is a novel inducer of rat liver and intestinal sulfotransferases |
| Q39025757 | Protective Effects of Thymoquinone against Methotrexate-Induced Germ Cell Apoptosis in Male Mice |
| Q36457546 | Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. |
| Q39537262 | The effect of N-acetylcysteine on the antitumor activity of ifosfamide |
| Q46758534 | Tumor suppressor protein p53 and anti-p53 autoantibodies in pediatric rheumatological diseases. |
Search more.